Physician profile
Michael Elevich
NPI 1811348907
$1,482.43
in general payments reported to CMS, 2019-2025
8 companies · $18.62 in 2025
The $18.62 reported for 2025 was less than what a typical Dentist provider received nationally (typical 2025 total: $70.27).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $151 · 2020: $382 · 2021: $150 · 2022: $31.68 · 2023: $112 · 2024: $637 · 2025: $18.62.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $475 · Food and Beverage: $293.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $475.00 |
| Food and Beverage | $292.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Straumann USA LLC | $1,088.12 | 2019-2024 | |
| Biohorizons Implant Systems INC. | $140.71 | 2024-2025 | Biohorizons, Biohorizons Dental Implants |
| Align Technology, INC. | $89.33 | 2020-2022 | |
| Kulzer, LLC | $83.84 | 2024 | |
| Dentsply Sirona INC | $36.86 | 2023 | Nupro, Cerec |
| Solventum Corporation | $15.92 | 2024 | 3m Espe Filtek Supreme Ultra Universal Restorative, 3m Scotchbond, Relyx |
| Elevate Oral Care | $15.39 | 2024 | Just Right 5000, Advantage Arrest, Fluorimax 5000 |
| Zimmer Biomet Holdings, INC. | $12.26 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Elevich listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.